VEON (VEON) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Krystal Biotech (KRYS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 26, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), announced today that, on January 28, 2026, the Company will implement a 1-for-4 reverse split of its common stock. The reverse stock split will be effective as of the morning of January 28, 2026, and the Company's common stock will trade on a post-split basis at the beginning of trading on the same date under the existing trading symbol "REVB.

Nvidia ( NASDAQ:NVDA ) first invested approximately $100 million in CoreWeave ( NASDAQ:CRWV ) in 2023 and added to its stake around CoreWeave's IPO last March.

Lands' End agreed to form a joint venture with brand management and acquisition company WHP Global in a deal that will provide the apparel company with $300 million in cash.

Alphabet Inc. shares have performed extremely well over the last year, but selling now could be a big mistake. Based on megatrend themes, significant competitive advantages and earnings growth trajectory, I expected the group of "Magnificent 7" megacap stocks, including Alphabet, to continue outperforming the S&P 500 index. This report ranks the Magnificent 7, including a special focus on Alphabet, and then concludes with my strong opinion on portfolio positioning going forward.

NOW eyes 19.5% Q4 subscription revenue growth, fueled by AI momentum, major partnerships and key acquisitions.

META leans on AI to boost ad growth ahead of Q4 results, but rising costs and Reality Labs losses weigh on its outlook.

Rivian Automotive plunged 27% in a month while R2 production appears on schedule. My base case remains that R2 demand will underwhelm and that Rivian will need additional capital. Despite downside risk, Rivian retains 'option value' tied to the R2 program and strong liquidity, limiting near-term downside.

Boston, Massachusetts--(Newsfile Corp. - January 26, 2026) - Block & Leviton is investigating Wealthfront Corp. (NASDAQ: WLTH) for potential securities law violations. Investors who have lost money in their Wealthfront Corp. investment should contact the firm to learn more about how they might recover those losses.

Jensen Huang has built a $4.6 trillion empire selling the picks and shovels of the AI revolution.

APH sees up to 65% EPS growth in Q4 2025, driven by AI demand, acquisitions and strength in key end markets.

According to the Internal Revenue Service (IRS), passive income generally includes earnings from rental activity or any trade, business, or investment in which the individual does not materially participate.

Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) has invested $2 billion in AI infrastructure provider CoreWeave (NASDAQ:CRWV) as part of an expanded strategic collaboration between the two companies. Under the terms of the investment, Nvidia purchased CoreWeave Class A common stock at a price of $87.20 per share.

PHILADELPHIA, Jan. 26, 2026 (GLOBE NEWSWIRE) -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against CoreWeave, Inc. (NASDAQ: CRWV) (“CoreWeave” or the “Company”) on behalf of investors who purchased or otherwise acquired CoreWeave securities during the period from March 28, 2025 through December 15, 2025 (the “Class Period”), inclusive.

Elon Musk admitted something Tesla bulls didn't want to hear: the Cybercab and Optimus rollout will be “agonizingly slow.